-
Je něco špatně v tomto záznamu ?
Pencil-beam scanning proton therapy for the treatment of glomus jugulare tumours
J. Kubeš, V. Vondráček, M. Andrlik, M. Navrátil, S. Sláviková, D. Klika, A. Haas, K. Dědečková, K. Kopečková, B. Ondrová, E. Rotnáglová, Š. Vinakurau, A. Grebenyuk, J. Rosina
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2013
Free Medical Journals
od 2013
PubMed Central
od 2013
Europe PubMed Central
od 2013
ProQuest Central
od 2004-04-01
Open Access Digital Library
od 2013-01-01
Open Access Digital Library
od 2013-01-01
Nursing & Allied Health Database (ProQuest)
od 2004-04-01
Health & Medicine (ProQuest)
od 2004-04-01
Health Management Database (ProQuest)
od 2004-04-01
Wiley-Blackwell Open Access Titles
od 2013
ROAD: Directory of Open Access Scholarly Resources
od 2013
PubMed
35973945
DOI
10.1002/jmrs.612
Knihovny.cz E-zdroje
- MeSH
- celková dávka radioterapie MeSH
- lidé MeSH
- plánování radioterapie pomocí počítače metody MeSH
- protonová terapie * škodlivé účinky metody MeSH
- protony MeSH
- radioterapie s modulovanou intenzitou * škodlivé účinky metody MeSH
- retrospektivní studie MeSH
- tumor glomus jugulare * etiologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
INTRODUCTION: Glomus jugulare tumours (GJT) are benign tumours that arise locally and destructively in the base of the skull and can be successfully treated with radiotherapy. Patients have a long-life expectancy and the late effects of radiotherapy can be serious. Proton radiotherapy reduces doses to critical organs and can reduce late side effects of radiotherapy. The aim of this study was to report feasibility and early clinical results of 12 patients treated using proton therapy. METHODS: Between December 2013 and June 2019, 12 patients (pts) with GJT (median volume 20.4 cm3 ; range 8.5-41 cm3 ) were treated with intensity modulated proton therapy (IMPT). Median dose was 54 GyE (Gray Equivalents) (50-60 GyE) with daily fractions of 2 GyE. Twelve patients were analysed with a median follow-up time of 42.2 months (11.3-86.7). Feasibility, dosimetric parameters, acute and late toxicity and local effect on tumour were evaluated in this retrospective study. RESULTS: All patients finished treatment without interruption, with excellent dosimetric parameters and mild acute toxicity. Stabilisation of tumour size was detected on MRI in all patients. No changes in symptoms were observed in comparison with pre-treatment conditions. No late effects of radiotherapy were observed. CONCLUSION: Pencil-beam scanning proton radiotherapy is highly feasible in the treatment of large GJT with mild acute toxicity and promising short-term results. Longer follow-up and larger patient cohorts are required to further identify the role of pencil-beam scanning (PBS) for this indication.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22032469
- 003
- CZ-PrNML
- 005
- 20240902105822.0
- 007
- ta
- 008
- 230120s2022 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/jmrs.612 $2 doi
- 035 __
- $a (PubMed)35973945
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Kubeš, Jiří $u Proton Therapy Centre Czech, Prague, Czech Republic $u Department of Oncology, 2nd Faculty of Medicine, Charles University Prague and Motol University Hospital, Prague, Czech Republic $u Department of Health Care Disciplines and Population Protection, Faculty of Biomedical Engineering, Czech Technical University Prague, Kladno, Czech Republic
- 245 10
- $a Pencil-beam scanning proton therapy for the treatment of glomus jugulare tumours / $c J. Kubeš, V. Vondráček, M. Andrlik, M. Navrátil, S. Sláviková, D. Klika, A. Haas, K. Dědečková, K. Kopečková, B. Ondrová, E. Rotnáglová, Š. Vinakurau, A. Grebenyuk, J. Rosina
- 520 9_
- $a INTRODUCTION: Glomus jugulare tumours (GJT) are benign tumours that arise locally and destructively in the base of the skull and can be successfully treated with radiotherapy. Patients have a long-life expectancy and the late effects of radiotherapy can be serious. Proton radiotherapy reduces doses to critical organs and can reduce late side effects of radiotherapy. The aim of this study was to report feasibility and early clinical results of 12 patients treated using proton therapy. METHODS: Between December 2013 and June 2019, 12 patients (pts) with GJT (median volume 20.4 cm3 ; range 8.5-41 cm3 ) were treated with intensity modulated proton therapy (IMPT). Median dose was 54 GyE (Gray Equivalents) (50-60 GyE) with daily fractions of 2 GyE. Twelve patients were analysed with a median follow-up time of 42.2 months (11.3-86.7). Feasibility, dosimetric parameters, acute and late toxicity and local effect on tumour were evaluated in this retrospective study. RESULTS: All patients finished treatment without interruption, with excellent dosimetric parameters and mild acute toxicity. Stabilisation of tumour size was detected on MRI in all patients. No changes in symptoms were observed in comparison with pre-treatment conditions. No late effects of radiotherapy were observed. CONCLUSION: Pencil-beam scanning proton radiotherapy is highly feasible in the treatment of large GJT with mild acute toxicity and promising short-term results. Longer follow-up and larger patient cohorts are required to further identify the role of pencil-beam scanning (PBS) for this indication.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a protonová terapie $x škodlivé účinky $x metody $7 D061766
- 650 12
- $a tumor glomus jugulare $x etiologie $7 D005925
- 650 _2
- $a protony $7 D011522
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 12
- $a radioterapie s modulovanou intenzitou $x škodlivé účinky $x metody $7 D050397
- 650 _2
- $a celková dávka radioterapie $7 D011879
- 650 _2
- $a plánování radioterapie pomocí počítače $x metody $7 D011880
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Vondráček, Vladimír $u Proton Therapy Centre Czech, Prague, Czech Republic $u Department of Health Care Disciplines and Population Protection, Faculty of Biomedical Engineering, Czech Technical University Prague, Kladno, Czech Republic
- 700 1_
- $a Andrlík, Michal $u Proton Therapy Centre Czech, Prague, Czech Republic $u Department of Health Care Disciplines and Population Protection, Faculty of Biomedical Engineering, Czech Technical University Prague, Kladno, Czech Republic $1 https://orcid.org/0000000165815583 $7 xx0322119
- 700 1_
- $a Navrátil, Matěj $u Proton Therapy Centre Czech, Prague, Czech Republic $u Department of Health Care Disciplines and Population Protection, Faculty of Biomedical Engineering, Czech Technical University Prague, Kladno, Czech Republic
- 700 1_
- $a Sláviková, Silvia $u Proton Therapy Centre Czech, Prague, Czech Republic $u Department of Oncology, 2nd Faculty of Medicine, Charles University Prague and Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Klika, Daniel $u Proton Therapy Centre Czech, Prague, Czech Republic
- 700 1_
- $a Haas, Alexandra $u Proton Therapy Centre Czech, Prague, Czech Republic $u Department of Oncology, 2nd Faculty of Medicine, Charles University Prague and Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Dědečková, Kateřina $u Proton Therapy Centre Czech, Prague, Czech Republic $u Department of Oncology, 2nd Faculty of Medicine, Charles University Prague and Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Kopečková, Kateřina $u Department of Oncology, 2nd Faculty of Medicine, Charles University Prague and Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Ondrová, Barbora $u Proton Therapy Centre Czech, Prague, Czech Republic $u Department of Oncology, 2nd Faculty of Medicine, Charles University Prague and Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Rotnáglová, Eliška $u Proton Therapy Centre Czech, Prague, Czech Republic $u Department of Oncology, 2nd Faculty of Medicine, Charles University Prague and Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Vinakurau, Štěpán $u Proton Therapy Centre Czech, Prague, Czech Republic $u Department of Oncology, 2nd Faculty of Medicine, Charles University Prague and Motol University Hospital, Prague, Czech Republic
- 700 1_
- $a Grebenyuk, Alexander $u Department of Health Protection and Disaster Medicine, Pavlov First Saint Petersburg State Medical University, Saint Petersburg, Russia
- 700 1_
- $a Rosina, Jozef $u Department of Health Care Disciplines and Population Protection, Faculty of Biomedical Engineering, Czech Technical University Prague, Kladno, Czech Republic $u Department of Medical Biophysics and Informatics, 3rd Faculty of Medicine, Charles University Prague, Prague, Czech Republic
- 773 0_
- $w MED00210176 $t Journal of medical radiation sciences $x 2051-3909 (online) $g Roč. 69, č. 4 (2022), s. 456-462
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35973945 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230120 $b ABA008
- 991 __
- $a 20240902105821 $b ABA008
- 999 __
- $a ok $b bmc $g 1891309 $s 1183804
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2022 $b 69 $c 4 $d 456-462 $e 20220816 $i 2051-3909 (online) $m Journal of medical radiation sciences $n J Med Radiat Sci $x MED00210176
- LZP __
- $a Pubmed-20230120